NextCompany

$18 Million Diabetes Supply Company located in the Southwest

Southwest Diabetes Supply Company with 5,000+ CGM Clients

On NextCompany since August 28, 2026 (today)

Location undisclosedEstablished 2015
Financial summary
Asking price
N/A
Gross revenue
$18,000,000
Cash flow (SDE)
N/A
EBITDA
$700,000

Figures come from the listing party and are not verified or guaranteed by NextCompany. Parts of this page are AI-generated and may contain errors. Verify everything before relying on it. See the Buyer Terms.

Business overview

A diabetes supply company in the Southwest focuses on CGM products. It maintains Medicare licensure and BOC accreditation. Medicare represents 80 percent of the payer mix. More than 5,000 active CGM clients generate weekly enrollments. 2025 EBITDA projects around $700,000. The owner stays willing for up to one year after sale.

Who is a good fit for this business

  • Strategic buyers adding over 5,000 CGM clients.
  • Acquirers expanding into East Coast and Southeast markets.
  • Operators comfortable with 80% Medicare payer mix.

Details

Frequently Asked Questions

The company specializes in continuous glucose monitoring and diabetic supplies.

More than 5,000 active CGM clients receive services. New enrollments occur each week. This base drives value for strategic buyers.

2024 gross revenue reached $18.06 million. 2025 EBITDA projects around $700,000. Medicare accounts for 80 percent of payers.

The owner remains willing for up to one year after sale. Expansion into East Coast and Southeast regions offers growth. The business holds Medicare licensure.

Similar businesses